Thus, not only are ACE inhibitors indispensable drugs for the clinical treatment of kidney diseases [71], but the selective experimental removal of components of the renal RAS, including renal ACE and renal AT1R, was also shown to protect mice against experimentally induced arterial hypertension [26, 25, 13,1 2]. The gene discussed is ACE; the disease is kidney disorder.